The U.S. government announced a long-awaited “access model” designed to blunt the cost that state Medicaid programs would pay for new sickle cell therapies.
Comments
( ̄□ ̄;)
There's nothing here…
The U.S. government announced a long-awaited “access model” designed to blunt the cost that state Medicaid programs would pay for new sickle cell therapies.